# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-044910
Filing Date
2025-05-16
Accepted
2025-05-16 16:30:15
Documents
19
Period of Report
2025-06-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea0240986-def14a_abvcbio.htm iXBRL | DEF 14A | 3069346
2 | GRAPHIC | image_001.jpg | GRAPHIC | 35654
3 | GRAPHIC | image_002.jpg | GRAPHIC | 21048
| Complete submission text file | 0001213900-25-044910.txt |  | 4028183

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | abvc-20241231.xsd | EX-101.SCH | 10389
5 | XBRL DEFINITION FILE | abvc-20241231_def.xml | EX-101.DEF | 1917
6 | XBRL LABEL FILE | abvc-20241231_lab.xml | EX-101.LAB | 35975
7 | XBRL PRESENTATION FILE | abvc-20241231_pre.xml | EX-101.PRE | 2239
21 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0240986-def14a_abvcbio_htm.xml | XML | 5419

Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40700 | Film No.: 25959746
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)